Craig Aspinwall, a University of Arizona professor of chemistry and biochemistry with joint appointments in the Department of Biomedical Engineering and at the BIO5 Institute, has developed new materials for detecting radioisotopes that provide higher resolution images for studying biochemistry and cell biology than the methods currently available.
Working through Tech Launch Arizona, Aspinwall and his co-inventor, Colleen Janczak, have started Scintillation Nanotechnologies LLC, a company that focuses on the development and manufacture of composite nanomaterials for detecting radioisotopes in biochemical research and drug discovery applications. Janczak serves as the chief operations officer and Aspinwall as the chief science officer.
“Working with the team from TLA helped us move from an isolated research project to thinking much bigger,” said Aspinwall.
Scintillation Nanotechnologies LLC, has four products that it formulates for direct sales to customers, and it continues to develop new technologies based on customer demand.